Google
MEDP — MEDPACE HOLDINGS INC (Healthcare >> Diagnostics & Research)
MEDP FAQ
What is MEDP's P/E ratio?
MEDPACE HOLDINGS INC (MEDP) currently trades at a P/E ratio of 27.64.
What is MEDP's ROE?
MEDPACE HOLDINGS INC reports a Return on Equity (ROE) of 76.95%.
What is MEDP's dividend yield?
MEDPACE HOLDINGS INC offers a dividend yield of 0.00%.
What is MEDP's Deepscope Quality Score?
Deepscope rates MEDP's overall financial quality at 69 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy MEDP?
Deepscope's AI Timing Score for MEDP is 50 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does MEDP belong to?
MEDPACE HOLDINGS INC is classified under the Healthcare >> Diagnostics & Research sector on the NASDAQ exchange.
|
USD 450.82
Price
5.23
(1.17%)
Day Change
|
|
|---|
MEDP, ファンダメンタルスコアはok ( ファンダメンタル = 69) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- NEUTRAL
- Signal Description
- Company financial health is OK
- Reason
-
ROEが昨年度比で低い
ROAがROEに比べて低い
ROAの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are ok , financial health is not quite good , and ability to make profit is ok , ...
| Deepscope 分析 |
|
61% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 72 |
| Magic Formula Rank by ROA |
856
|
| Magic Formula Rank by ROE |
856
|
| Magic Formula Rank by ROIC |
885
|
| Price | 450.82 |
| PBV / Sector |
21.27 / -23.97
|
| Earning Per Share | 16.31 |
| PE / Sector |
27.64 / 36.92
|
| PEG or PE/Growth / Sector |
0.97 / 1.37
|
| Average 1M Daily Value |
134.19 M
GREAT
|
| Average 1W Daily Value |
137.65 M
GREAT
|
| Timing Factors |
|
57% |
| Financial Health |
|
58% |
| ポイントになる統計 |
|
68% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-06-04 09:24:17 |
| Symbol | MEDP |
| Name | MEDPACE HOLDINGS INC |
| Sector | Healthcare >> Diagnostics & Research |
| Market | NASDAQ |
| Listed Shares | 28.56 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 12,725.91 / 31,486.64 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 5375 Medpace Way, Cincinnati, OH, United States, 45227
Phone: 513 579 9911
Website: https://www.medpace.com
Employees: 6,300
Description: Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
ME vs SECTOR Healthcare >> Diagnostics & Research
Click a bubble to view stock details · Bubble size represents market capitalization share
